PG
AMGN icon

Prostatis Group’s Amgen AMGN Stock Holding History

Prostatis Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Buy
1,965
+258
+15% +$88.3K 0.17% 92
2026
Q1 		$601K Buy
1,707
+81
+5% +$28.9K 0.15% 97
2025
Q4 		$532K Sell
1,626
-34
-2% -$10.8K 0.13% 101
2025
Q3 		$469K Sell
1,660
-64
-4% -$18.6K 0.12% 99
2025
Q2 		$481K Sell
1,724
-141
-8% -$39.9K 0.14% 98
2025
Q1 		$581K Sell
1,865
-456
-20% -$135K 0.18% 88
2024
Q4 		$605K Sell
2,321
-77
-3% -$22.8K 0.18% 93
2024
Q3 		$773K Buy
2,398
+222
+10% +$72.6K 0.25% 73
2024
Q2 		$680K Buy
2,176
+332
+18% +$97.5K 0.24% 81
2024
Q1 		$524K Buy
1,844
+527
+40% +$154K 0.2% 92
2023
Q4 		$379K Sell
1,317
-26
-2% -$7.08K 0.16% 96
2023
Q3 		$361K Sell
1,343
-111
-8% -$27.7K 0.18% 75
2023
Q2 		$323K Sell
1,454
-4,307
-75% -$999K 0.15% 86
2023
Q1 		$1.38M Sell
5,761
-370
-6% -$90.8K 0.73% 34
2022
Q4 		$1.61M Buy
6,131
+331
+6% +$88.7K 0.98% 28
2022
Q3 		$1.31M Buy
5,800
+4,596
+382% +$1.11M 1.51% 21
2022
Q2 		$293K Buy
1,204
+39
+3% +$9.56K 0.46% 25
2022
Q1 		$282K Buy
1,165
+10
+0.9% +$2.3K 0.23% 61
2021
Q4 		$260K Buy
1,155
+9
+0.8% +$1.9K 0.16% 85
2021
Q3 		$244K Sell
1,146
-41
-3% -$9.44K 0.15% 88
2021
Q2 		$289K Sell
1,187
-233
-16% -$57.3K 0.2% 85
2021
Q1 		$353K Buy
1,420
+33
+2% +$7.87K 0.28% 79
2020
Q4 		$319K Buy
1,387
+136
+11% +$31.4K 0.27% 65
2020
Q3 		$318K Buy
1,251
+66
+6% +$16.4K 0.3% 64
2020
Q2 		$279K Buy
1,185
+12
+1% +$2.74K 0.56% 52
2020
Q1 		$238K Sell
1,173
-47
-4% -$10.3K 0.34% 42
2019
Q4 		$294K Buy
+1,220
New +$269K 0.27% 65

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Prostatis Group's AMGN Position: Q2 2026 in Review

Prostatis Group increased its Amgen (AMGN) stake by 15% in Q2 2026, buying an estimated $88.3K and bringing the position to 1,965 shares worth $712K. The position accounts for 0.17% of the portfolio, ranked #92.

Prostatis Group first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.61M in Q4 2022. 3,148 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Prostatis Group held 1,965 shares of Amgen worth $712K as of Q2 2026.
  • Prostatis Group bought 258 Amgen shares in Q2 2026, an estimated $88.3K.
  • Amgen made up 0.17% of Prostatis Group's portfolio in Q2 2026, its #92 holding.
  • Prostatis Group first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Prostatis Group's Amgen position peaked at $1.61M in Q4 2022.
  • 3,148 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.